Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection

Ngā tūemi rite

• Genetically engineered live-attenuated cytomegalovirus (CMV) vaccines improve pregnancy outcome in the guinea-pig model of congenital CMV infection
  mā: Cui Xiaohong, me ētahi atu.
  I whakaputaina: (2008-04-01)
• Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome
  mā: Cui Xiaohong, me ētahi atu.
  I whakaputaina: (2008-11-01)
• Circularization and cleavage of guinea pig cytomegalovirus genomes.
  mā: McVoy, M A, me ētahi atu.
  I whakaputaina: (1997)
• Inclusion of the Guinea Pig Cytomegalovirus Pentameric Complex in a Live Virus Vaccine Aids Efficacy against Congenital Infection but Is Not Essential for Improving Maternal and Neonatal Outcomes
  mā: Mark R. Schleiss, me ētahi atu.
  I whakaputaina: (2021-11-01)
• An Attenuated Cytomegalovirus Vaccine with a Deletion of a Viral Chemokine Gene Is Protective against Congenital CMV Transmission in a Guinea Pig Model
  mā: Michael P. Leviton, me ētahi atu.
  I whakaputaina: (2013-01-01)